Abstract Search

ey0015.13-11 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15

13.11 Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa

A Rowlands , E Ameyaw , F Rutagarama , J Dipsesalema , ES Majaliwa , J Mbogo , GD Ogle , JP Chanoine

To read the full abstract: Horm Res Paediatr. 2018; Jul 26:1-1As the global burden of non-communicable diseases (NCD) is rising to epidemic levels worldwide, efforts are underway to build capacity for childhood NCDs in low- and middle-income countries (LMICs), including among health care providers in pediatric endocrinology. With increased ability to recognize and diagnose pediatric endocrine conditi...

0 shares

ey0019.13-6 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.6. Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean region: it takes a village…

A Rowlands , A Deeb , A Ladjouze , RT Hamza , SA Musa , J Raza , F Jennane , A Abu-Libdeh , JP Chanoine , the GPED CAH Working Group

jchanoine@cw.bc.ca BMJ Global Health 2021;6:e007195. doi: 10.1136/bmjgh-2021-007195Brief Summary: This review found that access to oral fludrocortisone and hydrocortisone remains suboptimal in the WHO Eastern Mediterranean Region. Improvement requires a collaboration between health professionals, families of patients, health authorities, pharmaceutica...

0 shares

ESPE Yearbook of Paediatric Endocrinology

13.11 Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa

13.6. Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean region: it takes a village…

BiosciAbstracts